Miller et al1 pointed out the underutilization of lipid-lowering therapy in patients with coronary artery disease, especially in women.
We would like to present comparable results from the Bavarian Cholesterol Screening Project, which was initiated in 1988 as a population-based study.2,3 Within the screening period of 10 years (1988-1998), 193,188 persons (54% women and 46% men) were screened all over Bavaria. Total cholesterol was measured by the Reflotron portable cholesterol analyzer (Boehringer Mannheim, Mannheim, Germany). For each person a short medical history was taken. The mean ± SD ages were 53 ± 17 years for the 104,244 screened women and 50 ± 18 years for the 88,944 screened men. The mean ± SD cholesterol levels were 6.24 ± 1.37 mmol/L (241 ± 53 mg/dL) for the women and 5.88 ± 1.40 mmol/L (227 ± 54 mg/dL) for the men.
Laubach E, Otto C, Schwandt P. Toward Better Therapy of Hypercholesterolemia. Arch Intern Med. 2000;160(17):2685–2686. doi:
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: